Literature DB >> 25608614

Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study.

Okechukwu S Ogah1, Beth A Davison, Karen Sliwa, Bongani M Mayosi, Albertino Damasceno, Mahmoud U Sani, Charles Mondo, Anastase Dzudie, Dike B Ojji, Charles Kouam, Ahmed Suliman, Neshaad Schrueder, Gerald Yonga, Sergine Abdou Ba, Fikru Maru, Bekele Alemayehu, Christopher Edwards, Gad Cotter.   

Abstract

BACKGROUND: The impact of gender on the clinical characteristics, risk factors, co-morbidities, etiology, treatment and outcome of acute heart failure in sub-Saharan Africa has not been described before. The aim of this study was to evaluate the sex differences in acute heart failure in sub-Saharan Africa using the data from The sub-Saharan Africa Survey of Heart Failure (THESUS-HF). METHODS AND
RESULTS: 1,006 subjects were recruited into this prospective multicenter, international observational heart failure survey. The mean age of total population was 52.4 years (54.0 years for men and 50.7 years for women). The men were significantly older (p = 0.0045). Men also presented in poorer NYHA functional class (III and IV), p = 0.0364). Cigarette smoking and high blood pressure were significantly commoner in men (17.3 vs. 2.6% and 60.0 vs. 51.0% respectively). On the other hand, atrial fibrillation and valvular heart disease were significantly more frequent in women. The mean hemoglobin concentration was lower in women compared to men (11.7 vs. 12.6 g/dl, p ≤ 0.0001), while the blood urea and creatinine levels were higher in men (p < 0.0001). LV systolic dysfunctional was also seen more in men. Men also had higher E/A ratio indicating higher LV filling pressure. Outcomes were similar in both sexes.
CONCLUSIONS: Although the outcome of patients admitted for AHF in sub-Saharan regions is similar in men and women, some gender differences are apparent suggesting that in men more emphasis should be put on modifiable life risk factors, while in women prevention of rheumatic heart diseases and improved nutrition should be addressed vigorously.

Entities:  

Mesh:

Year:  2015        PMID: 25608614     DOI: 10.1007/s00392-015-0810-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  31 in total

1.  Heart failure in sub-saharan Africa: time for action.

Authors:  Albertino Damasceno; Gad Cotter; Anastase Dzudie; Karen Sliwa; Bongani M Mayosi
Journal:  J Am Coll Cardiol       Date:  2007-10-23       Impact factor: 24.094

2.  More 'malignant' than cancer? Five-year survival following a first admission for heart failure.

Authors:  S Stewart; K MacIntyre; D J Hole; S Capewell; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

3.  Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project.

Authors:  Saif S Rathore; JoAnne Micale Foody; Yongfei Wang; Jeph Herrin; Frederick A Masoudi; Edward P Havranek; Diana L Ordin; Harlan M Krumholz
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

4.  Gender differences in survival in advanced heart failure. Insights from the FIRST study.

Authors:  K F Adams; C A Sueta; M Gheorghiade; C M O'Connor; T A Schwartz; G G Koch; B Uretsky; K Swedberg; W McKenna; J Soler-Soler; R M Califf
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

5.  Gender differences among Norwegian patients with heart failure.

Authors:  Bjorn Brandsaeter; Dan Atar; Stefan Agewall
Journal:  Int J Cardiol       Date:  2009-08-22       Impact factor: 4.164

Review 6.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa.

Authors:  Bongani M Mayosi
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

7.  Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients.

Authors:  Peter M Okin; Richard B Devereux; Markku S Nieminen; Sverker Jern; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Sverre E Kjeldsen; Stevo Julius; Steven Snapinn; Björn Dahlöf
Journal:  Hypertension       Date:  2004-06-01       Impact factor: 10.190

8.  Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.

Authors:  Tom D J Smilde; Kevin Damman; Pim van der Harst; Gerjan Navis; B Daan Westenbrink; Adriaan A Voors; Frans Boomsma; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Clin Res Cardiol       Date:  2008-10-31       Impact factor: 5.460

9.  Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

Authors:  Marie Galvao; Jill Kalman; Teresa DeMarco; Gregg C Fonarow; Catherine Galvin; Jalal K Ghali; Robert M Moskowitz
Journal:  J Card Fail       Date:  2006-03       Impact factor: 5.712

10.  Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities.

Authors:  Simon Stewart; David Wilkinson; Craig Hansen; Vinesh Vaghela; Robert Mvungi; John McMurray; Karen Sliwa
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

View more
  18 in total

1.  Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF).

Authors:  Abel Makubi; Camilla Hage; Ulrik Sartipy; Johnson Lwakatare; Mohammed Janabi; Peter Kisenge; Ulf Dahlström; Lars Rydén; Julie Makani; Lars H Lund
Journal:  Int J Cardiol       Date:  2016-06-29       Impact factor: 4.164

2.  How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry.

Authors:  Òscar Miró; Víctor Gil; Christian Müller; Alexander Mebazaa; Héctor Bueno; Francisco Javier Martín-Sánchez; Pablo Herrero; Javier Jacob; Pere Llorens
Journal:  Clin Res Cardiol       Date:  2015-04-24       Impact factor: 5.460

3.  Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

Authors:  F Aus dem Siepen; R Bauer; A Voss; S Hein; M Aurich; J Riffel; D Mereles; C Röcken; S J Buss; H A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2017-09-27       Impact factor: 5.460

4.  Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.

Authors:  Dimitrios Farmakis; Panagiotis Simitsis; Vasiliki Bistola; Filippos Triposkiadis; Ignatios Ikonomidis; Spyridon Katsanos; George Bakosis; Erifili Hatziagelaki; John Lekakis; Alexandre Mebazaa; John Parissis
Journal:  Clin Res Cardiol       Date:  2016-12-20       Impact factor: 5.460

Review 5.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

6.  Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.

Authors:  Piercarlo Ballo; Irene Betti; Alessandro Barchielli; Daniela Balzi; Gabriele Castelli; Leonardo De Luca; Mihai Gheorghiade; Alfredo Zuppiroli
Journal:  Clin Res Cardiol       Date:  2015-11-07       Impact factor: 5.460

7.  Soy Isoflavone Protects Myocardial Ischemia/Reperfusion Injury through Increasing Endothelial Nitric Oxide Synthase and Decreasing Oxidative Stress in Ovariectomized Rats.

Authors:  Yan Tang; Shuangyue Li; Ping Zhang; Jinbiao Zhu; Guoliang Meng; Liping Xie; Ying Yu; Yong Ji; Yi Han
Journal:  Oxid Med Cell Longev       Date:  2016-02-01       Impact factor: 6.543

8.  Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Authors:  Gerasimos Filippatos; Dimitrios Farmakis; Marco Metra; Gad Cotter; Beth A Davison; G Michael Felker; Barry H Greenberg; Tsushung A Hua; Peter S Pang; Piotr Ponikowski; Min Qian; Thomas A Severin; Adriaan A Voors; John R Teerlink
Journal:  Clin Res Cardiol       Date:  2017-02-01       Impact factor: 5.460

Review 9.  Guideline-Directed Medical Therapy in Females with Heart Failure with Reduced Ejection Fraction.

Authors:  Anubha Agarwal; Sanne A E Peters; Chanchal Chandramouli; Carolyn S P Lam; Gemma A Figtree; Clare Arnott
Journal:  Curr Heart Fail Rep       Date:  2021-07-02

Review 10.  Valvular heart diseases in women.

Authors:  Ghada Youssef
Journal:  Egypt Heart J       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.